I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert whose extensive experience in research and development, paired with a passion for technology and innovation, has positioned him at the forefront of transformative advancements in the industry. Today, we’ll dive into the
In the ever-evolving landscape of healthcare, where technology and patient care intersect, few individuals stand out as prominently as David Mulherin, a clinical informatics pharmacist and lead application analyst at Vanderbilt University Medical Center (VUMC) in Nashville, Tennessee. His
Imagine a patient facing major surgery, anxious about the risks and uncertain about recovery, only to discover that a tailored preparation plan could dramatically lower complications and improve outcomes. This isn’t a far-off dream but a reality backed by groundbreaking research from a leading
Multiple myeloma, a challenging blood cancer, affects thousands of individuals annually, often progressing from a precursor condition known as high-risk smoldering multiple myeloma (HR-SMM). With around 50% of HR-SMM cases advancing to active disease within just a couple of years, the stakes are
I'm thrilled to sit down with Ivan Kairatov, a seasoned biopharma expert with a wealth of experience in research and development. With a sharp focus on technology and innovation, Ivan has been at the forefront of advancing biologics formulation, particularly in tackling the complex challenges of
In the heart of Sudan, a nation gripped by unrelenting conflict, the provision of medical care, particularly anesthesia for surgical procedures, teeters on the edge of collapse due to systemic challenges and ongoing violence that have devastated infrastructure and resources. The city of Wad Medani
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27